Trial Profile
Study of Letermovir Salvage for Complicated Cases of Resistant CMV
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Nov 2018
Price :
$35
*
At a glance
- Drugs Letermovir (Primary)
- Indications Cytomegalovirus infections
- Focus Adverse reactions; Therapeutic Use
- 13 Nov 2018 New trial record
- 07 Oct 2018 Results presented at the IDWeek 2018